Regulation of peroxisome proliferator-activated receptor-gamma in liver fibrosis. (Q54595302)

1 June 2018

title

Regulation of peroxisome proliferator-activated receptor-gamma in liver fibrosis. (English)

1 reference

1 June 2018

author name string

Liu Yang

1

1 reference

1 June 2018

Che-Chang Chan

2

1 reference

1 June 2018

Oh-Sang Kwon

3

1 reference

1 June 2018

Songling Liu

4

1 reference

1 June 2018

Jason McGhee

5

1 reference

1 June 2018

Stephen A Stimpson

6

1 reference

1 June 2018

Lihong Z Chen

7

1 reference

1 June 2018

W Wallace Harrington

8

1 reference

1 June 2018

William T Symonds

9

1 reference

1 June 2018

Don C Rockey

10

1 reference

1 June 2018

publication date

22 June 2006

1 reference

1 June 2018

American Journal of Physiology - Gastrointestinal and Liver Physiology

published in

1 reference

1 June 2018

volume

291

1 reference

1 June 2018

page(s)

G902-11

1 reference

1 June 2018

issue

5

1 reference

1 June 2018

Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00124.2006

PPAR gamma is required for placental, cardiac, and adipose tissue development

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00124.2006

Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00124.2006

A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00124.2006

Nuclear receptors and lipid physiology: opening the X-files

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00124.2006

Peroxisome proliferation-activated receptor (PPAR)gamma is not necessary for synthetic PPARgamma agonist inhibition of inducible nitric-oxide synthase and nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00124.2006

Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00124.2006

The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00124.2006

Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00124.2006

Hepatic lipocytes: the principal collagen-producing cells of normal rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00124.2006

Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00124.2006

Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00124.2006

Peroxisome proliferator-activated receptor-beta signaling contributes to enhanced proliferation of hepatic stellate cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00124.2006

Adenovirus-mediated in vivo gene transfer and expression in normal rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00124.2006

Reciprocal regulation of inflammation and lipid metabolism by liver X receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00124.2006

Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00124.2006

Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00124.2006

Vitamin A-containing lipocytes and formation of type III collagen in liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00124.2006

Autoregulation of the human liver X receptor alpha promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00124.2006

Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00124.2006

PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00124.2006

Collagen measured in primary cultures of normal rat hepatocytes derives from lipocytes within the monolayer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00124.2006

Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00124.2006

Peroxisome proliferator-activated receptors and hepatic stellate cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00124.2006

Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00124.2006

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00124.2006

The role of alpha1beta1 integrin in wound contraction. A quantitative analysis of liver myofibroblasts in vivo and in primary culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00124.2006

Cellular localization of endothelin-1 and increased production in liver injury in the rat: potential for autocrine and paracrine effects on stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00124.2006

Structure of the extracellular matrix in normal and fibrotic liver: collagens and glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00124.2006

Dose-dependent inhibition of hepatic fibrosis in mice by a TGF-beta soluble receptor: implications for antifibrotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00124.2006

Adenovirus-mediated gene transfer to nonparenchymal cells in normal and injured liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00124.2006

Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00124.2006

21 January 2018

Identifiers

DOI

10.1152/AJPGI.00124.2006

1 reference

1 June 2018

PubMed ID

16798724

1 reference

1 June 2018